Tagged with Top 10

Mexico Here we highlight the top 10 pharma companies in Mexico based on IQVIA data from February MAT 2020. Four of the top ten companies are Mexican: PISA, Sanfer, Senosiain and Siegfried Rhein.   Made with Visme Infographic Maker

Opinion 2019 was a year of innovation and disruption in the life sciences industry. From artificial intelligence to cell and gene therapy, and from generics and biosimilars to geopolitics and healthcare reform, PharmaBoardroom is proud to have collaborated with industry thought leaders to publish their insights on the year’s top trends…

China China’s booming pharmaceutical industry has been rapidly expanding to become the second largest pharmaceutical market globally. The following are the top ten Chinese pharma companies from 2018, with revenues reaching over USD 1 billion.      Sinopharm Group CEO: Yong Liu HKEx 1099:HK Sinopharm Group, the largest member of the China…

UAE The top 10 pharma companies in the UAE ranked by 2018 sales according to IQVIA data. Swiss giant Novartis leads the way with USD 196 million in sales, followed by GSK on 129 million and AstraZeneca with 126 million.   Made with Visme Infographic Maker

Rankings The MEA market has reached $25B in value, growing at 8% CAGR; short term growth stood at 10% from 2017 to 2018. Saudi Arabia, the largest market in MEA at $8.2B in value, grew at 7% in value terms. Egypt, Algeria and UAE are other large markets that had double-digit…

MEA These 10 corporations represent 37% of the MEA market by value. Novo Nordisk’s USD 635M growth is mainly driven by Norditropin (somatropin), Victoza (liraglutide) & Saxenda (liraglutide) which have grown at 60%, 18% and 190% PPG respectively. Hikma’s USD 497M growth has been the fastest due to Remox (amoxicillin) and…

Rankings These ten Chinese pharma companies ranked by 2018 revenues, each brought in more than a billion US dollars. Sinopharm comes out on top with revenues of USD 48.5 billion. Made with Visme Infographic Maker

Top 10 Novartis takes the top spot for the third consecutive year, while Takeda reports the highest growth.   

Rankings A new report from specialist pharma and biotech consultancy Novasecta explores how the world’s top 100 pharma companies are shaping the future of healthcare. Through an examination of the various business models and key value drivers being applied by the top 100, a picture emerges of the successful modern pharma…

Rankings A new report from specialist pharma and biotech consultancy Novasecta explores how the world’s top 100 pharma companies are shaping the future of healthcare. Novasecta’s Global 100 is based on total group revenues (2018) of all organisations that have pharmaceutical interests, with the aim of benchmarking industry performance in its fullest context.    …

Top 10 The Top 10 bestselling orphan drugs in the USA in 2017. Celgene’s Revlimid (generic name lenolidamide) leads the way with sales of USD 5.4 billion, followed by Roche’s Rituxan (rituximab) with USD 4.2 billion in sales and TEVA’s Copaxone (glatiramer acetate) with USD 3.1 billion. The most expensive drug in…

Top 10 The top 10 companies in the world ranked by global orphan drug sales and market share in 2017. Swiss giants Novartis and Roche take the top two places, followed by American firm, Celgene. Made with Visme Infographic Maker